The interaction of activated factor VII with tissue factor: Insight into the mechanism of cofactor-mediated activation of activated factor VII

Blood Coagulation and Fibrinolysis

Volumn 9, Issue SUPPL. 1, 1998, Pages

  Ruf, W ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Extended substrate recognition; Factor VIIa; Serine protease allosteric activation; TF FVIIa complex formation; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7; PHOSPHOLIPID; SERINE PROTEINASE; THROMBOPLASTIN;

ALLOSTERISM; AMINO ACID SEQUENCE; ANGIOGENESIS; BLOOD CLOTTING; CATALYSIS; CONFERENCE PAPER; CRYSTALLOGRAPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYDROLYSIS; MUTAGENESIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; THROMBOGENESIS;

EID: 0031785359     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 1994; 8:385-390.
2. Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol 1996; 3:379-384.
3. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernández-Ortiz A, et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95:594-599.
4. Moreno PR, Bernardi VH, López-Cuéllar J, Murcia AM, Palacios IF, Gold HK, et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina: implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 1996; 94:3090-3097.
5. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86:2839-2843.
6. Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, et al. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993; 91:2253-2259.
7. Speidel CM, Eisenberg PR, Ruf W, Edgington TS, Abendschein DR. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. Circulation 1995; 92:3323-3330.
8. Ragni M, Cirillo P, Pascucci I, Scognamiglio A, D'Andrea D, Eramo N, et al. Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation 1996; 93:1913-1918.
9. Erlich JH, Holdsworth SR, Tipping PG. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis. Am J Pathol 1997; 150:873-880.
10. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, et al. Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94:1226-1232.
11. Golino P, Ragni M, Cirillo P, Avvedimento VE, Feliciello A, Esposito N, et al. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nature Med 1996; 2:35-40.
12. Jude B, Agraou B, McFadden EP, Susen S, Bauters C, Lepelley P, et al. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation 1994; 90:1662-1668.
13. Harlos K, Martin DMA, O'Brien DP, Jones EY, Stuart DI, Polikarpov I, et al. Crystal structure of the extracellular region of human tissue factor. Nature 1994; 370:662-666.
14. Muller YA, Ultsch MH, Kelley RF, De Vos AM. Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site. Biochemistry 1994; 33:10864-10870.
15. Banner DW, D'Arcy A, Chène C, Winkler FK, Guha A, Konigsberg WH, et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996; 380:41-46.
16. Martin DMA, Boys CWG, Ruf W. Tissue factor: molecular recognition and cofactor function. FASEB J 1995; 9:852-859.
17. O'Brien DP, Kemball-Cook G, Hutchinson AM, Martin DMA, Johnson DJD, Byfield PGH, et al. Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q). Biochemistry 1994; 33:14162-14169.
18. Dickinson CD, Kelly CR, Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci USA 1996; 93:14379-14384.
19. 2+ binding to the first epidermal growth factor module of coagulation factor VIIa is important for cofactor interaction and proteolytic function. J Biol Chem 1997; 272:17467-17472.
20. Schullek JR, Ruf W, Edgington TS. Key ligand interface residues in tissue factor contribute independently to factor VIIa binding. J Biol Chem 1994; 269:19399-19403.
21. Ruf W, Rehemtulla A, Morrissey JH, Edgington TS. Phospholipid independent and dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 1991; 266:2158-2166.
22. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76:1-16.
23. Ruf W, Kelly CR, Schullek JR, Martin DMA, Polikarpov I, Boys CWG, et al. Energetic contributions and topographical organization of ligand binding residues of tissue factor. Biochemistry 1995; 34:6310-6315.
24. Ruf W, Schullek JR, Stone MJ, Edgington TS. Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry 1994; 33:1565-1572.
25. Kelley RF, Costas KE, O'Connell MP, Lazarus RA. Analysis of the factor VIIa binding site on human tissue factor: effects of tissue factor mutations on the kinetics and thermodynamics of binding. Biochemistry 1995; 34:10383-10392.
26. Gibbs C, McCurdy S, Leung L, Paborsky L. Identification of the factor VIIa binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis. Biochemistry 1994; 33:14003-14010.
27. Higashi S, Nishimura H, Aita K, Iwanaga S. Identification of regions of bovine factor VII essential for binding to tissue factor. J Biol Chem 1994; 269:18891-18898.
28. 44 regulates catalytic function of the bound protease factor VIIa. Biochem J 1996; 315:145-151.
29. + binding site of thrombin. J Biol Chem 1995; 270:22089-22092.
30. Huber R, Bode W. Structural basis of the activation and action of trypsin. Accounts Chem Res 1978; 11:114-122.
31. Bode W, Schwager P, Huber R. The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 Å resolution. J Mol Biol 1978; 118:99-112.
32. Higashi S, Matsumoto N, Iwanaga S. Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity. J Biol Chem 1996; 271:26569-26574.
33. Sørensen BB, Persson E, Freskgård P-O, Kjalke M, Ezban M, Williams T, Rao LVM. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J Biol Chem 1997; 272:11863-11868.
34. Dickinson CD, Ruf W. Active site modification of factor VIIa affects interactions of the protease domain with tissue factor. J Biol Chem 1997; 272:19875-19879.
35. Baugh RJ, Krishnaswamy S. Role of the activation peptide domain in human factor X activation by the extrinsic Xase complex. J Biol Chem 1996; 271:16126-16134.
36. 192. Biochemistry 1995; 34:8701-8707.
37. 290 is required for efficient activation of the macromolecular substrate factor X. Biochemistry 1994; 33:11631-11636.
38. Wildgoose P, Foster D, Schiodt J, Wiberg FC, Birktoft JJ, Petersen LC. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction. Biochemistry 1993; 32:114-119.
39. Ruf W, Kalnik MW, Lund-Hansen T, Edgington TS. Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions. J Biol Chem 1991; 266:15719-15725.
40. Dittmar S, Ruf W, Edgington TS. Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation. Biochem J 1997; 321:787-793.
41. Ruf W, Miles DJ, Rehemtulla A, Edgington TS. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. J Biol Chem 1992; 267:6375-6381.
42. 166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X. J Biol Chem 1996; 271:21752-21757.
43. Rao LVM, Ruf W. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor-VIIa with Xa-tissue factor pathway inhibitor. Biochemistry 1995; 34:10867-10871.
44. +14→Lys) and its functional consequences in a hereditary factor X deficiency (factor X 'Vorarlberg'). J Biol Chem 1990; 265:11982-11989.
45. St Louis II: identification of a glycine substitution at residue 7 and characterization of the recombinant protein. J Biol Chem 1996; 271:28601-28606.